Related Experiment Video
Updated: May 3, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Recent highlights in anti-protozoan drug development and resistance research
Frederick S Buckner1, Norman C Waters2, Vicky M Avery3
1Department of Medicine, University of Washington, Seattle, WA 98195-7185, United States.
Abstract:
This article summarizes the highlights of research presented in January, 2012, at the Keystone Symposium on "Drug Discovery for Protozoan Parasites" held in Santa Fe, New Mexico. This symposium which convenes approximately every 2 years provides a forum for leading investigators around the world to present data covering basic sciences to clinical trials relating to anti-protozoan drug development and drug resistance. Many talks focused on malaria, but other protozoan diseases receiving attention included African sleeping sickness, Chagas disease, leishmaniasis, cryptosporidiosis, and amoebiasis. The new research, most of it unpublished, provided insights into the latest developments in the field.
Related Concept Videos
Anthelminthic Agents
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Treatment Resistant Cancers
Treatment Resistent Cancers
Mechanism of Antibiotic Resistance in MRSA

